Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,413

Featured

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for

Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,

Location: Austin TX, Oklahoma City OK, Nashville TN,

Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase2, Recruiting

Featured

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

for

Schizophrenia

Location: Austin TX, Richardson TX, Little Rock AR,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07145918

Phase2, Recruiting

Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for

Chronic Lymphocytic Leukemia

Location: Austin TX, Dallas TX, Tulsa OK, Kansas City MO,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting

Featured

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

for

Ovarian Cancer

Location: San Antonio TX, Denver CO, Chicago IL,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07278336

Phase1, Recruiting

Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for

Solid Tumors Harboring MET Amplification

Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,

Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting

Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for

Non-Small Cell Lung Cancer,

Location: San Antonio TX, Austin TX, Houston TX, Irving TX,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting

Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for

Crohn's Disease

Location: San Antonio TX, Cedar Park TX, Houston TX, Mansfield TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for

Bipolar I Disorder, Bipolar II Disorder

Location: Austin TX, Missouri City TX, The Woodlands TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for

Migraine

Location: Austin TX, Birmingham AL, Tampa FL, Summerville SC,

Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

for

Mid Face Volume Deficit

Location: Austin TX, Metairie LA, Birmingham AL, Atlanta GA,

Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT06734351

Phase3, Recruiting

FeaturedActive & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for

Rheumatoid Arthritis

Location: Austin TX, Corpus Christi TX, Houston TX, Katy TX,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for

Major Depressive Disorder

Location: Austin TX, Bellaire TX, Richardson TX, Oklahoma City OK,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for

Hypothyroidism

Location: San Antonio TX, Shavano Park TX, Austin TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for

Squamous Cell Carcinoma of Head and Neck

Location: Fredericksburg TX, Waco TX, Houston TX, Dallas TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase3, Recruiting

Maestro 1.1 Post-Market Registry

for

Surgery

Location: Cedar Park TX, Denver CO, Jacksonville FL,

Sponsor: Moon Surgical

Sex: All

Age: 18 - 70+

Code: NCT06103136

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for

Bronchiolitis Acute

Location: Austin TX, Belton TX, Houston TX, The Woodlands TX,

Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

for

Colo-rectal Cancer

Location: Austin TX

Sponsor: Natera, Inc.

Sex: All

Age: 40+

Code: NCT07046585

Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

for

Non-Hodgkin Lymphoma, T-Cell Lymphoma,

Location: Austin TX

Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07750886

Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

for

Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer,

Location: Austin TX

Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07318051

Recruiting

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

for

Colorectal Cancer Screening

Location: Austin TX

Sponsor: Natera, Inc.

Sex: All

Age: 40+

Code: NCT06620627

Recruiting

Paid Clinical Trials New Braunfels

Filter results

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

Interested in new trials?

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Maestro 1.1 Post-Market Registry

I-DECIDE After Bronchiolitis Hospitalization

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Sample Collection for Ongoing Research and Product Evaluation Study

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection